CD40 and myeloid sarcoma: The physiologic effect of CD40 stimulation, on the other hand, is to increase brain-derived neurotrophic factor (BDNF) release and exhibit neuroprotective effects, which are lacking in MS patients despite rising CD40 expression in their monocytes, leading to deviated immunity in MS and persistent CNS neuronal loss [201].